Valuation: Artivion, Inc.

Market Cap 128.98Cr 111.93Cr 104.81Cr 96Cr 180.99Cr 12TCr 183.36Cr 1.23TCr 481.2Cr 6.14TCr 484.27Cr 473.74Cr 20TCr P/E 2026 *
317x
P/E 2027 * 65.2x
Enterprise Value 128.98Cr 111.93Cr 104.81Cr 96Cr 180.99Cr 12TCr 183.36Cr 1.23TCr 481.2Cr 6.14TCr 484.27Cr 473.74Cr 20TCr EV / Sales 2026 *
2.65x
EV / Sales 2027 * 2.39x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day+6.64%
1 week-3.31%
Current month-3.31%
1 month+10.38%
3 months-20.95%
6 months-29.52%
Current year-40.08%
1 week 22.6
Extreme 22.6
23.8
1 month 20
Extreme 20
24.2
Current year 17.4
Extreme 17.4
38.9
1 year 17.4
Extreme 17.4
41.1
3 years 11.7
Extreme 11.7
41.1
5 years 10.1
Extreme 10.1
41.1
10 years 10.1
Extreme 10.1
41.1
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Director/Board Member 61 01/05/2012
Change 5-day change 1-year change 3-year change Capi.($)
+6.64%-3.31% - - 128.98Cr
+2.13%+2.23%-17.54%+0.29% 19TCr
-0.08%+0.25%-3.85%+2.24% 11TCr
+2.46%+4.09%+14.53%+75.37% 6.2TCr
+0.41%+3.67%+36.75%+53.08% 5.38TCr
+3.76%+7.02%+2.70%-34.61% 4.88TCr
-5.88%-11.78% - - 3.03TCr
+0.44%+11.38%+8.66%-31.01% 3.13TCr
-0.69%+2.65%+46.92%-7.06% 2.45TCr
-0.40%+0.25%+4.78%+2.55% 2.26TCr
Average +0.88%+2.42%+11.62%+7.61% 6.33TCr
Weighted average by Cap. +0.99%+2.55%+1.56%+9.36%

Financials

2026 *2027 *
Net sales 49Cr 42Cr 40Cr 36Cr 68Cr 4.63TCr 69Cr 462.24Cr 181.4Cr 2.31TCr 182.56Cr 178.59Cr 7.7TCr 54Cr 47Cr 44Cr 40Cr 76Cr 5.14TCr 77Cr 513.14Cr 201.38Cr 2.57TCr 202.67Cr 198.26Cr 8.55TCr
Net income 44L 38.18L 35.75L 32.71L 61.74L 42Cr 62.55L 4.18Cr 1.64Cr 21Cr 1.65Cr 1.62Cr 70Cr 2.26Cr 1.96Cr 1.84Cr 1.68Cr 3.17Cr 215.16Cr 3.21Cr 21Cr 8.43Cr 107.5Cr 8.48Cr 8.3Cr 357.8Cr
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change
07/26/07 23.40 +3.54%
06/26/06 €22.60 -3.42%
05/26/05 €23.40 -1.68%
04/26/04 €23.80 0.00%
03/26/03 €23.80 -1.65%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
26.57USD
Average target price
42.00USD
Spread / Average Target
+58.07%

Quarterly revenue - Rate of surprise